Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 4,535.00
-135.00 (-2.89%)
At close: Mar 19, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 123.65 billion as of March 20, 2026. Its market cap has increased by 25.38% in one year.
Market Cap
123.65B
Enterprise Value
106.56B
Revenue
25.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,535.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 123.65B, an increase of 40.69%. That is a compound annual growth rate of 4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 123.65B | -40.38% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 466.26B |
| Dx & Vx | 435.05B |
| GENINUS | 204.45B |
| HLB Panagene | 117.54B |
| Green Cross Medical Science | 77.94B |
| Protia | 62.26B |
| Seoulin Bioscience | 57.20B |
| GeneMatrix | 42.01B |